Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C12H14N2O3 |
| Molecular Weight | 234.2512 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC2=CC=CC=C2C(=O)N1CC(O)CO
InChI
InChIKey=NTGLQWGMESPVBV-UHFFFAOYSA-N
InChI=1S/C12H14N2O3/c1-8-13-11-5-3-2-4-10(11)12(17)14(8)6-9(16)7-15/h2-5,9,15-16H,6-7H2,1H3
| Molecular Formula | C12H14N2O3 |
| Molecular Weight | 234.2512 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Diproqualone was used primarily for the treatment of inflammatory pain associated with osteoarthritis. The analgesic activity of diproqualoneis synergistic with that of noramidopyrine. It also display anti-inflammatory action in the rat, inhibiting plantar edema with dextran or serotonin, atopic edema from ovalbumin, etc. It has spasmolytic, anticholinergic and antihistaminic action in higher doses. It is not hypnotic and has no anticonvulsant effects. The therapeutic symptoms for diproqualone are all types of pain: postoperative, posttraumatic, dental, neuritis, anti-inflammatory arthritis, etc.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:18:21 GMT 2025
by
admin
on
Mon Mar 31 18:18:21 GMT 2025
|
| Record UNII |
QY7HLH8V4L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Mon Mar 31 18:18:21 GMT 2025 , Edited by admin on Mon Mar 31 18:18:21 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB07226MIG
Created by
admin on Mon Mar 31 18:18:21 GMT 2025 , Edited by admin on Mon Mar 31 18:18:21 GMT 2025
|
PRIMARY | |||
|
100000082354
Created by
admin on Mon Mar 31 18:18:21 GMT 2025 , Edited by admin on Mon Mar 31 18:18:21 GMT 2025
|
PRIMARY | |||
|
Diproqualone
Created by
admin on Mon Mar 31 18:18:21 GMT 2025 , Edited by admin on Mon Mar 31 18:18:21 GMT 2025
|
PRIMARY | |||
|
36518-02-2
Created by
admin on Mon Mar 31 18:18:21 GMT 2025 , Edited by admin on Mon Mar 31 18:18:21 GMT 2025
|
PRIMARY | |||
|
64112
Created by
admin on Mon Mar 31 18:18:21 GMT 2025 , Edited by admin on Mon Mar 31 18:18:21 GMT 2025
|
PRIMARY | |||
|
2737
Created by
admin on Mon Mar 31 18:18:21 GMT 2025 , Edited by admin on Mon Mar 31 18:18:21 GMT 2025
|
PRIMARY | |||
|
253-081-1
Created by
admin on Mon Mar 31 18:18:21 GMT 2025 , Edited by admin on Mon Mar 31 18:18:21 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106200
Created by
admin on Mon Mar 31 18:18:21 GMT 2025 , Edited by admin on Mon Mar 31 18:18:21 GMT 2025
|
PRIMARY | |||
|
QY7HLH8V4L
Created by
admin on Mon Mar 31 18:18:21 GMT 2025 , Edited by admin on Mon Mar 31 18:18:21 GMT 2025
|
PRIMARY | |||
|
DTXSID30865821
Created by
admin on Mon Mar 31 18:18:21 GMT 2025 , Edited by admin on Mon Mar 31 18:18:21 GMT 2025
|
PRIMARY | |||
|
C65433
Created by
admin on Mon Mar 31 18:18:21 GMT 2025 , Edited by admin on Mon Mar 31 18:18:21 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |